AIDS Therapies

Nevirapine Can Be Safe, Effective for Salvage Treatment

Published in AIDS Weekly, February 19th, 2001

by Michael Greer, staff medical writer -- The reverse transcriptase inhibitor nevirapine can be safely and effectively used as a salvage therapy for HIV patients who have shown resistance to other antiviral treatments, according to researchers in The Netherlands.

F.W.N.M. Wit and colleagues at the University of Amsterdam conducted a study to "assess the tolerability, virological, immunological, and clinical effects of nevirapine in the setting of a compassionate use program in pretreated HIV infected individuals." The results of their research were published in the journal Antiviral Therapy.

Wit et al. recruited 187 HIV positive volunteers...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-02-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry